SEC Tracker
Get the app

Dyne Therapeutics DYN

Atlas Venture Fund XI, L.P., planned sale of DYN shares

Form
144
Filed
Importance
Routine

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Dyne Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float $300M to $2B, nearest public float first, as each company reports it on its annual report cover.

  1. Collegium Pharmaceutical COLL public float $926M, Jun 30, 2025
  2. CorMedix CRMD public float $910M, Jun 30, 2025
  3. Harrow HROW public float $1.0B, Jun 30, 2025
  4. Geron GERN public float $861M, Jun 30, 2025
  5. Syndax Pharmaceuticals SNDX public float $799M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.